School of Public Health and Health Sciences, University of Massachusetts, Amherst, 715 N. Pleasant Street, Amherst, MA 01003, USA.
BMC Pediatr. 2013 Apr 15;13:55. doi: 10.1186/1471-2431-13-55.
Type 1 diabetes is among the most prevalent chronic childhood diseases in the US. Initial type 1 diabetes management education and care can take place in different clinical settings. This study assessed metabolic outcomes (i.e. hemoglobin A1C), healthcare utilization and costs among new-onset type 1 diabetic children who received initial diabetes education and care in a hospital compared to those children in an outpatient pediatric endocrinology clinic.
A retrospective cross-sectional study was conducted from the payer's perspective. New-onset type 1 diabetic children, aged 1-18, presented at Baystate Children's Hospital (Massachusetts) from 2008-2009 were included in the study if lab test confirmed diagnosis and there was one year of follow-up. Inpatients spent at least one night in the hospital during a 10-day diagnosis period and received all or part of diabetes education there. Outpatients were diagnosed and received all diabetes education in a pediatric endocrinology clinic. Metabolic outcomes were measured at diagnosis and at one year post-diagnosis. Healthcare charges and electronic medical records data were reviewed from 2008-2010. Healthcare costs components included diagnostic test, pediatric, endocrinology and hospitalists care, critical and emergency care, type 1 diabetes related supplies, prescription drugs, and IV products.
Study sample included 84 patients (33 inpatient and 51 outpatients). No statistically significant differences in patient demographic characteristics were found between groups. There were no statistically significant differences in metabolic outcomes between groups. Total cost at one year post-diagnosis per new-onset type 1 diabetic child was $12,332 and $5,053 in the inpatient and outpatient groups, respectively. The average healthcare cost for pediatric endocrinology care was $4,080 and $3,904 per child in the inpatient and outpatient groups, respectively.
Provision of initial type 1 diabetes education and care to new-onset non-critically ill children in a hospital setting increases healthcare costs without improving patient's glycemic control in the first year post-diagnosis.
1 型糖尿病是美国最常见的儿童慢性疾病之一。1 型糖尿病的初始管理教育和护理可以在不同的临床环境中进行。本研究评估了在医院接受初始糖尿病教育和护理的新发 1 型糖尿病儿童与在儿科内分泌门诊接受教育的儿童之间的代谢结果(即血红蛋白 A1C)、医疗保健利用和成本。
从支付者的角度进行回顾性横断面研究。2008 年至 2009 年在马萨诸塞州贝赛斯达儿童医院就诊的新诊断为 1 型糖尿病的 1-18 岁儿童,如果实验室检测确认诊断且有一年的随访期,则纳入本研究。住院患者在 10 天的诊断期间至少有一晚住院,并在那里接受全部或部分糖尿病教育。门诊患者在儿科内分泌门诊诊断并接受所有糖尿病教育。代谢结果在诊断时和诊断后一年进行测量。审查了 2008 年至 2010 年的医疗保健费用和电子病历数据。医疗保健费用包括诊断测试、儿科、内分泌和医院医生护理、重症和急诊护理、1 型糖尿病相关用品、处方药和静脉产品。
研究样本包括 84 名患者(33 名住院患者和 51 名门诊患者)。两组患者的人口统计学特征无统计学差异。两组间代谢结果无统计学差异。新发 1 型糖尿病儿童在诊断后一年的总费用为 12332 美元,住院组为 5053 美元。住院组和门诊组儿童的儿科内分泌科护理平均医疗费用分别为 4080 美元和 3904 美元。
在医院环境中为非危急新发 1 型糖尿病儿童提供初始 1 型糖尿病教育和护理会增加医疗保健费用,而不会改善患者在诊断后第一年的血糖控制。